Tynor
August 2026
Announced Date: August 2026
Value: USD 200 million
o3 Capital acted as the Exclusive Financial Advisor to Tynor on its majority stake sale to Kedaara.
We are pleased to announce that our client, Tynor, has entered into a definitive agreement for a majority stake sale to Kedaara for USD 200 Mn.
The transaction marks another milestone for o3 Capital in the Consumer Healthcare sector, reflecting our deep understanding of Tynor's business and growth journey, and our ability to position the company at the intersection of med-tech and consumer health.
Speaking on the transaction, Shashank Pandey, Managing Director at o3 Capital, said: “Tynor is a rare Indian consumer healthcare success story - a doctor-trusted brand built over three decades with genuine scale, product depth and global ambition. At o3 Capital, we believe in advisory that goes beyond the transaction, and it has been a privilege to partner with Dr. Pushvinder Jit Singh and the Tynor team on this journey. We believe Kedaara's operating expertise and long-term orientation make it the right partner for Tynor's next phase of growth.”
Dr. Pushvinder Jit Singh, MD & CEO of Tynor, said: “With an absolute pride and a heart full of joy, we welcome, Kedaara Capital. Big aspiration of Tynor to become the leader of global south and an indispensable supply chain partner for Global north shall now be achieved by having Kedaara as a partner. o3 Capital has been a trusted advisor throughout this process. Their understanding of our business, and hands-on execution were instrumental in navigating the complexities of the transaction, and we deeply value their partnership across key milestones in our growth.”
Tynor, founded in 1993, is India's #1 doctor-recommended orthotics brand (Nielsen survey) and a market leader in orthopaedic supports, mobility aids, rehabilitation and sports performance solutions. The company is present in over 300,000 retail outlets, 8,000 hospitals and 60 countries, and has touched more than 100 million lives. Born from the belief that healthcare should be affordable, accessible and proactive, Tynor is a testament to India's homegrown capability, with every product designed to exceed global standards.
Kedaara is an operationally oriented private equity firm pursuing control and minority investment opportunities in India. It currently manages over USD 6 billion through investments in several market-leading businesses across sectors including healthcare and pharma, financial services, consumer, and technology services. Since inception, Kedaara has remained dedicated towards trust-based relationships with best-in-class entrepreneurs and management teams in fast-growing end markets.
About o3 Capital
o3 Capital is a leading mid-market investment bank focused on delivering differentiated outcomes across private equity, M&A, structured finance, and strategic advisory. With deep sector expertise and long-standing client relationships, o3 Capital partners with entrepreneurs and institutions to drive transformational growth and value creation.
We are pleased to announce that our client, Tynor, has entered into a definitive agreement for a majority stake sale to Kedaara for USD 200 Mn.
The transaction marks another milestone for o3 Capital in the Consumer Healthcare sector, reflecting our deep understanding of Tynor's business and growth journey, and our ability to position the company at the intersection of med-tech and consumer health.
Speaking on the transaction, Shashank Pandey, Managing Director at o3 Capital, said: “Tynor is a rare Indian consumer healthcare success story - a doctor-trusted brand built over three decades with genuine scale, product depth and global ambition. At o3 Capital, we believe in advisory that goes beyond the transaction, and it has been a privilege to partner with Dr. Pushvinder Jit Singh and the Tynor team on this journey. We believe Kedaara's operating expertise and long-term orientation make it the right partner for Tynor's next phase of growth.”
Dr. Pushvinder Jit Singh, MD & CEO of Tynor, said: “With an absolute pride and a heart full of joy, we welcome, Kedaara Capital. Big aspiration of Tynor to become the leader of global south and an indispensable supply chain partner for Global north shall now be achieved by having Kedaara as a partner. o3 Capital has been a trusted advisor throughout this process. Their understanding of our business, and hands-on execution were instrumental in navigating the complexities of the transaction, and we deeply value their partnership across key milestones in our growth.”
Tynor, founded in 1993, is India's #1 doctor-recommended orthotics brand (Nielsen survey) and a market leader in orthopaedic supports, mobility aids, rehabilitation and sports performance solutions. The company is present in over 300,000 retail outlets, 8,000 hospitals and 60 countries, and has touched more than 100 million lives. Born from the belief that healthcare should be affordable, accessible and proactive, Tynor is a testament to India's homegrown capability, with every product designed to exceed global standards.
Kedaara is an operationally oriented private equity firm pursuing control and minority investment opportunities in India. It currently manages over USD 6 billion through investments in several market-leading businesses across sectors including healthcare and pharma, financial services, consumer, and technology services. Since inception, Kedaara has remained dedicated towards trust-based relationships with best-in-class entrepreneurs and management teams in fast-growing end markets.
About o3 Capital
o3 Capital is a leading mid-market investment bank focused on delivering differentiated outcomes across private equity, M&A, structured finance, and strategic advisory. With deep sector expertise and long-standing client relationships, o3 Capital partners with entrepreneurs and institutions to drive transformational growth and value creation.